Monitoring of low-risk patients with papillary thyroid carcinoma [2]

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 9, 2003, Pages 4507-

  Menzel, Christian ^a,b   Grünwald, Frank ^b   Biersack, Hans J ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 131; RECOMBINANT THYROTROPIN;

ALGORITHM; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; LETTER; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVE CONTAMINATION; THORAX RADIOGRAPHY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; TUMOR VOLUME; URINARY EXCRETION; WHOLE BODY SCINTISCANNING;

CARCINOMA, PAPILLARY, FOLLICULAR; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; HUMANS; RECOMBINANT PROTEINS; RISK; THYROGLOBULIN; THYROID NEOPLASMS; THYROTROPIN; WHOLE-BODY COUNTING;

EID: 0141564516     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030951     Document Type: Letter

References (2)

1. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A 2003 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433-1441
2. Pacini F, Molinaro E, Castagna MG, Lippi F, Ceccarelli C, Agate L, Elisei R, Pinchera A 2002 Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab 87:4063-4068